MEI Pharma, Inc. Press Releases

MEIP 
$3.69
*  
0.10
2.64%
Get MEIP Alerts
*Delayed - data as of Jan. 23, 2015  -  Find a broker to begin trading MEIP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
NIRI San Diego Elects 2015 Board Members
12/22/2014 4:05:00 PM - PR Newswire
▼-12.35 % Price Change since this news event. The Volume Ratio is 1.3.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


MEI Pharma Reaches Response Milestone in Phase II Clinical Trial of Pracinostat in Refractory Myelodysplastic Syndrome
12/22/2014 9:00:00 AM - PR Newswire


MEI Pharma Completes Public Offering of Common Stock
12/17/2014 4:05:00 PM - PR Newswire
▼-11.51 % Price Change since this news event. The Volume Ratio is 0.28.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


MEI Pharma Announces Pricing Of Public Offering Of Common Stock
12/12/2014 8:00:00 AM - PR Newswire
▼-12.14 % Price Change since this news event. The Volume Ratio is 13.27.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


MEI Pharma Announces $45 Million Proposed Public Offering of Common Stock
12/10/2014 4:01:00 PM - PR Newswire
▼-31.54 % Price Change since this news event. The Volume Ratio is 3.15.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


MEI Pharma Reports Significant Clinical Activity In Phase II Study Of Pracinostat In Front Line Acute Myeloid Leukemia
12/8/2014 8:30:00 AM - PR Newswire
▼-41.89 % Price Change since this news event. The Volume Ratio is 27.9.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


MEI Pharma Announces Election of Pharmaceutical Industry Veteran Kevan Clemens to Board of Directors
12/4/2014 6:00:00 AM - PR Newswire


MEI Pharma Completes Enrollment in Phase II Study of Pracinostat in Front Line Acute Myeloid Leukemia
12/2/2014 8:30:00 AM - PR Newswire
▼-42.34 % Price Change since this news event. The Volume Ratio is 0.97.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


MEI Pharma To Host Analyst And Investor Event
12/1/2014 9:00:00 AM - PR Newswire
▼-42.25 % Price Change since this news event. The Volume Ratio is 2.21.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


MEI Pharma To Host Annual Meeting Of Stockholders
11/26/2014 9:00:00 AM - PR Newswire


MEI Pharma to Present at Stifel Healthcare Conference
11/12/2014 9:00:00 AM - PR Newswire
▼-53.88 % Price Change since this news event. The Volume Ratio is 0.39.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


MEI Pharma Reports Improved Response Rates in Phase II Study of Pracinostat in Front Line Acute Myeloid Leukemia
11/6/2014 9:01:00 AM - PR Newswire
▼-53.88 % Price Change since this news event. The Volume Ratio is 5.12.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


MEI Pharma Advances Clinical Study Of Mitochondrial Inhibitor ME-344 In Small Cell Lung And Ovarian Cancers
10/29/2014 8:30:00 AM - PR Newswire
▼-53.23 % Price Change since this news event. The Volume Ratio is 16.99.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day